Mike Whelan
Keine laufenden Positionen mehr
Profil
Mike Whelan worked as a Director and Director of Research & Development at iQur Ltd.
and as a Principal at Onyvax Ltd.
Ehemalige bekannte Positionen von Mike Whelan
| Unternehmen | Position | Ende |
|---|---|---|
iQur Ltd.
 iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 25.07.2016 |
Onyvax Ltd.
 Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Onyvax Ltd. developed cancer remedy therapies. The company was founded in 1995 and was headquartered in Bradford, the United Kingdom. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Health Technology |
Onyvax Ltd.
Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Onyvax Ltd. developed cancer remedy therapies. The company was founded in 1995 and was headquartered in Bradford, the United Kingdom. | Commercial Services |
